China SXT Pharmaceuticals, Inc. (SXTC) Stock Analysis & Investment Frameworks
China SXT Pharmaceuticals, Inc. (SXTC) stock analysis on Invetso. Review China SXT Pharmaceuticals, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
China SXT Pharmaceuticals, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: CN
China SXT Pharmaceuticals, Inc. Key Financial Metrics
- Market Cap: $1.35M
- Revenue: $1.07M
- ROE: -31.02%
- ROIC: -23.34%
- Dividend Yield: N/A
About China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
China SXT Pharmaceuticals, Inc. Investment Frameworks
Invetso analyzes China SXT Pharmaceuticals, Inc. (SXTC) across the following frameworks:
- China SXT Pharmaceuticals, Inc. 10Y Growth Potential
- China SXT Pharmaceuticals, Inc. Scenario Analysis
- China SXT Pharmaceuticals, Inc. Risks & Opportunities
- China SXT Pharmaceuticals, Inc. Economic Moat
- China SXT Pharmaceuticals, Inc. Business Model
- China SXT Pharmaceuticals, Inc. Management
- China SXT Pharmaceuticals, Inc. SWOT Analysis
- China SXT Pharmaceuticals, Inc. Porter's 5 Forces
- China SXT Pharmaceuticals, Inc. PESTLE Analysis
- China SXT Pharmaceuticals, Inc. ESG Analysis
